Advanced search
Publication Cover
COPD: Journal of Chronic Obstructive Pulmonary Disease Volume 1, 2004 - Issue 2
Submit an article Journal homepage
748
Views
58
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Development of Self‐Administered Versions of Modified Baseline and Transition Dyspnea Indexes in COPD

Donald A. Mahler Section of Pulmonary and Critical Medicine, Dartmouth‐Hitchcock Medical Center, One Medical Center Drive, Lebanon, New Hampshire, 03756‐0001, USA
, M.D.,
Joseph Ward Section of Pulmonary and Critical Medicine, Dartmouth‐Hitchcock Medical Center, One Medical Center Drive, Lebanon, New Hampshire, 03756‐0001, USA
, RCPT,
Gustavo Fierro‐Carrion Section of Pulmonary and Critical Medicine, Dartmouth‐Hitchcock Medical Center, One Medical Center Drive, Lebanon, New Hampshire, 03756‐0001, USA
, M.D.,
Laurie A. Waterman Section of Pulmonary and Critical Medicine, Dartmouth‐Hitchcock Medical Center, One Medical Center Drive, Lebanon, New Hampshire, 03756‐0001, USA
, B.S.,
Timothy F. Lentine Section of Pulmonary and Critical Medicine, Dartmouth‐Hitchcock Medical Center, One Medical Center Drive, Lebanon, New Hampshire, 03756‐0001, USA
, RCPT,
Roberto Mejia‐Alfaro Section of Pulmonary and Critical Medicine, Dartmouth‐Hitchcock Medical Center, One Medical Center Drive, Lebanon, New Hampshire, 03756‐0001, USA
, M.D. &
John C. Baird Section of Pulmonary and Critical Medicine, Dartmouth‐Hitchcock Medical Center, One Medical Center Drive, Lebanon, New Hampshire, 03756‐0001, USA; Psychological Applications, Waterbury, VermontUSA
, Ph.D. show all
Pages 165-172 | Published online: 18 Aug 2004

Citations (58)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (9)

Seon Cheol Park, Narongkorn Saiphoklang, Jonathan Phillips, May-Lin Wilgus, Russell G Buhr, Donald P Tashkin, Christopher B Cooper & Igor Barjaktarevic. (2023) Three-Month Variability of Commonly Evaluated Biomarkers in Clinically Stable COPD. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 1475-1486.
Read now
Nicola A Hanania & Denis E O'Donnell. (2019) Activity-related dyspnea in chronic obstructive pulmonary disease: physical and psychological consequences, unmet needs, and future directions. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1127-1138.
Read now
Andreas von Leupoldt, Thomas Reijnders, Michael Schuler, Michael Wittmann, Danijel Jelusic & Konrad Schultz. (2017) Validity of a Self-administered Questionnaire Version of the Transition Dyspnea Index in Patients with COPD. COPD: Journal of Chronic Obstructive Pulmonary Disease 14:1, pages 66-71.
Read now
Mario Cazzola, Nicola Alexander Hanania, William MacNee, Katja Rüdell, Claire Hackford & Nihad Tamimi. (2015) A review of the most common patient-reported outcomes in COPD – revisiting current knowledge and estimating future challenges. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 725-738.
Read now
Donald A. Mahler, Joseph Ward, Laurie A. Waterman & John C. Baird$suffix/text()$suffix/text(). (2012) Longitudinal Changes in Patient-reported Dyspnea in Patients with COPD. COPD: Journal of Chronic Obstructive Pulmonary Disease 9:5, pages 522-527.
Read now
Paul Jones, Marc Miravitlles, Thys van der Molen & Karoly Kulich. (2012) Beyond FEV1 in COPD: a review of patient-reported outcomes and their measurement. International Journal of Chronic Obstructive Pulmonary Disease 7, pages 697-709.
Read now
Alex H. Gifford, Donald A. Mahler, Laurie A. Waterman, Joseph Ward, William J. Kraemer, Brian R. Kupchak & John C. Baird. (2011) Neuromodulatory Effect of Endogenous Opioids on the Intensity and Unpleasantness of Breathlessness during Resistive Load Breathing in COPD. COPD: Journal of Chronic Obstructive Pulmonary Disease 8:3, pages 160-166.
Read now
Donald A Mahler & Theodore J Witek$suffix/text()$suffix/text(). (2005) The MCID of the Transition Dyspnea Index is a Total Score of One Unit. COPD: Journal of Chronic Obstructive Pulmonary Disease 2:1, pages 99-103.
Read now
Barry Make. (2004) Alphabet Soup: Assessment of Dyspnea. COPD: Journal of Chronic Obstructive Pulmonary Disease 1:2, pages 151-152.
Read now

Articles from other publishers (49)

Elizabeth R. Volkmann, Holly Wilhalme, Shervin Assassi, Grace Hyun J. Kim, Jonathan Goldin, Masataka Kuwana, Donald P. Tashkin & Michael D. Roth. (2023) Combining Clinical and Biological Data to Predict Progressive Pulmonary Fibrosis in Patients With Systemic Sclerosis Despite Immunomodulatory Therapy. ACR Open Rheumatology.
Crossref
Elizabeth R. Volkmann, Donald P. Tashkin, Mei Leng, Grace Hyun J. Kim, Jonathan Goldin & Michael D. Roth. (2023) Association of Symptoms of Gastroesophageal Reflux, Esophageal Dilation, and Progression of Systemic Sclerosis–Related Interstitial Lung Disease. Arthritis Care & Research 75:8, pages 1690-1697.
Crossref
Harkiran K. Kooner, Marrissa J. McIntosh, Alexander M. Matheson, Mohammed Abdelrazek, Mitchell S. Albert, Inderdeep Dhaliwal, Miranda Kirby, Alexei Ouriadov, Giles E. Santyr, Carmen Venegas, Nisarg Radadia, Sarah Svenningsen, J. Michael Nicholson & Grace Parraga. (2023) Postacute COVID-19 Syndrome: 129 Xe MRI Ventilation Defects and Respiratory Outcomes 1 Year Later . Radiology 307:2.
Crossref
M. Beaumont, A.C. Latiers & G. Prieur. (2023) Le rôle du kinésithérapeute dans l’évaluation et la gestion de la dyspnée. Revue des Maladies Respiratoires 40:2, pages 169-187.
Crossref
Sezgi Şahin Duyar, Dicle Kaymaz & Michele Vitacca. 2023. Airway diseases. Airway diseases 1 23 .
Sangmee Sharon Bae, Lila Pourzand, Grace Hyun Kim, Bianca E Villegas, Andrea Oh, Daniel E Furst, Jonathan Goldin & Donald P Tashkin. (2021) The disconnect between visual assessment of air trapping and lung physiology for assessment of small airway disease in scleroderma-related interstitial lung disease: An observation from the Scleroderma Lung Study II Cohort. Journal of Scleroderma and Related Disorders 7:2, pages 117-127.
Crossref
Harkiran K Kooner, Marrissa J McIntosh, Alexander M Matheson, Carmen Venegas, Nisarg Radadia, Terence Ho, Ehsan Ahmed Haider, Norman B Konyer, Giles E Santyr, Mitchell S Albert, Alexei Ouriadov, Mohamed Abdelrazek, Miranda Kirby, Inderdeep Dhaliwal, J Michael Nicholson, Parameswaran Nair, Sarah Svenningsen & Grace Parraga. (2022) 129 Xe MRI ventilation defects in ever-hospitalised and never-hospitalised people with post-acute COVID-19 syndrome . BMJ Open Respiratory Research 9:1, pages e001235.
Crossref
Seon-Cheol Park, Narongkorn Saiphoklang, Donghyun Jung, David Gomez, Jonathan E. Phillips, Brett A. Dolezal, Donald P. Tashkin, Igor Barjaktarevic & Christopher B. Cooper. (2022) Use of a Wearable Biosensor to Study Heart Rate Variability in Chronic Obstructive Pulmonary Disease and Its Relationship to Disease Severity. Sensors 22:6, pages 2264.
Crossref
Fernando J. Martinez, Klaus F. Rabe, Gary T. Ferguson, Jadwiga A. Wedzicha, Roopa Trivedi, Martin Jenkins, Patrick Darken, Magnus Aurivillius & Paul Dorinsky. (2021) Benefits of budesonide/glycopyrrolate/formoterol fumarate (BGF) on symptoms and quality of life in patients with COPD in the ETHOS trial. Respiratory Medicine 185, pages 106509.
Crossref
Fernando J. Martinez, Brian J. Lipworth, Klaus F. Rabe, David J. Collier, Gary T. Ferguson, Sanjay Sethi, Gregory J. Feldman, Gerald O’Brien, Martin Jenkins & Colin Reisner. (2020) Benefits of glycopyrrolate/formoterol fumarate metered dose inhaler (GFF MDI) in improving lung function and reducing exacerbations in patients with moderate-to-very severe COPD: a pooled analysis of the PINNACLE studies. Respiratory Research 21:1.
Crossref
Claus F. Vogelmeier & Peter Alter. (2020) Assessing Symptom Burden. Clinics in Chest Medicine 41:3, pages 367-373.
Crossref
Maggie Tabberer, C. Elaine Jones, Sally Kilbride, David M. G. Halpin, David A. Lomas, Steven Pascoe, Dave Singh, Robert A. Wise, Gerard J. Criner, Peter Lange, Mark T. Dransfield, MeiLan K. Han, Fernando J. Martinez, Morrys C. Kaisermann & David A. Lipson. (2020) Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study. Advances in Therapy 37:9, pages 3775-3790.
Crossref
Elizabeth R. Volkmann, Donald P. Tashkin, Holly LeClair, Michael D. Roth, Grace Kim, Jonathan Goldin, Philip J. Clements, Daniel E. Furst & Dinesh Khanna. (2020) Treatment With Mycophenolate and Cyclophosphamide Leads to Clinically Meaningful Improvements in Patient‐Reported Outcomes in Scleroderma Lung Disease: Results of Scleroderma Lung Study II. ACR Open Rheumatology 2:6, pages 362-370.
Crossref
Elizabeth R. Volkmann, Donald P. Tashkin, Myung Sim, Ning Li, Dinesh Khanna, Michael D. Roth, Philip J. Clements, Anna-Maria Hoffmann-Vold, Daniel E. Furst, Grace Kim, Jonathan Goldin & Robert M. Elashoff. (2019) Cyclophosphamide for Systemic Sclerosis-related Interstitial Lung Disease: A Comparison of Scleroderma Lung Study I and II. The Journal of Rheumatology 46:10, pages 1316-1325.
Crossref
Magnus Ekström. (2019) Why treatment efficacy on breathlessness in laboratory but not daily life trials? The importance of standardized exertion. Current Opinion in Supportive & Palliative Care 13:3, pages 179-183.
Crossref
Anthony D’Urzo, Kenneth R. Chapman, James F. Donohue, Peter Kardos, M. Reza Maleki-Yazdi & David Price. (2019) Inhaler Devices for Delivery of LABA/LAMA Fixed-Dose Combinations in Patients with COPD. Pulmonary Therapy 5:1, pages 23-41.
Crossref
Elizabeth R Volkmann, Donald P Tashkin, Myung Sim, Ning Li, Ellen Goldmuntz, Lynette Keyes-Elstein, Ashley Pinckney, Daniel E Furst, Philip J Clements, Dinesh Khanna, Virginia Steen, Dean E Schraufnagel, Shiva Arami, Vivien Hsu, Michael D Roth, Robert M Elashoff & Keith M Sullivan. (2019) Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts. Annals of the Rheumatic Diseases 78:1, pages 122-130.
Crossref
Gary Deng, Marc B. Feinstein, Lara Benusis, Amy L. Tin & Diane E. Stover. (2019) Pilot Study of Self-care Breath Training Exercise for Reduction of Chronic Dyspnea. Journal of Cardiopulmonary Rehabilitation and Prevention 39:1, pages 56-59.
Crossref
Jonathan G. Goldin, Grace Hyun J. Kim, Chi-Hong Tseng, Elizabeth Volkmann, Daniel Furst, Philip Clements, Matt Brown, Michael Roth, Dinesh Khanna & Donald P. Tashkin. (2018) Longitudinal Changes in Quantitative Interstitial Lung Disease on Computed Tomography after Immunosuppression in the Scleroderma Lung Study II. Annals of the American Thoracic Society 15:11, pages 1286-1295.
Crossref
Maggie Tabberer, David A. Lomas, Ruby Birk, Noushin Brealey, Chang-Qing Zhu, Steve Pascoe, Nicholas Locantore & David A. Lipson. (2018) Once-Daily Triple Therapy in Patients with COPD: Patient-Reported Symptoms and Quality of Life. Advances in Therapy 35:1, pages 56-71.
Crossref
Elizabeth R. Volkmann, Donald P. Tashkin, Ning Li, Michael D. Roth, Dinesh Khanna, Anna-Maria Hoffmann-Vold, Grace Kim, Jonathan Goldin, Philip J. Clements, Daniel E. Furst & Robert M. Elashoff. (2017) Mycophenolate Mofetil Versus Placebo for Systemic Sclerosis-Related Interstitial Lung Disease: An Analysis of Scleroderma Lung Studies I and II. Arthritis & Rheumatology 69:7, pages 1451-1460.
Crossref
David S. Demos, Mark F. Berry, Leah M. Backhus & Joseph B. Shrager. (2017) Video-assisted thoracoscopic diaphragm plication using a running suture technique is durable and effective. The Journal of Thoracic and Cardiovascular Surgery 153:5, pages 1182-1188.
Crossref
Donald P. Tashkin, Elizabeth R. Volkmann, Chi-Hong Tseng, Michael D. Roth, Dinesh Khanna, Daniel E. Furst, Philip J. Clements, Arthur Theodore, Suzanne Kafaja, Grace Hyun Kim, Jonathan Goldin, Edgar Ariolla & Robert M. Elashoff. (2017) Improved Cough and Cough-Specific Quality of Life in Patients Treated for Scleroderma-Related Interstitial Lung Disease. Chest 151:4, pages 813-820.
Crossref
Dave Singh, Marc Miravitlles & Claus Vogelmeier. (2016) Chronic Obstructive Pulmonary Disease Individualized Therapy: Tailored Approach to Symptom Management. Advances in Therapy 34:2, pages 281-299.
Crossref
Takeshi Nakamura, Masatsugu Okamura & Takuya Saeki. (2017) Evaluatian of Dyspnea. The Japanese Journal of Rehabilitation Medicine 54:12, pages 941-946.
Crossref
Jamie Sheth & MeiLan Han. 2017. COPD. COPD 147 168 .
Donald P Tashkin, Michael D Roth, Philip J Clements, Daniel E Furst, Dinesh Khanna, Eric C Kleerup, Jonathan Goldin, Edgar Arriola, Elizabeth R Volkmann, Suzanne Kafaja, Richard Silver, Virginia Steen, Charlie Strange, Robert Wise, Fredrick Wigley, Maureen Mayes, David J Riley, Sabiha Hussain, Shervin Assassi, Vivien M Hsu, Bela Patel, Kristine Phillips, Fernando Martinez, Jeffrey Golden, M Kari Connolly, John Varga, Jane Dematte, Monique E Hinchcliff, Aryeh Fischer, Jeffrey Swigris, Richard Meehan, Arthur Theodore, Robert Simms, Suncica Volkov, Dean E Schraufnagel, Mary Beth Scholand, Tracy Frech, Jerry A Molitor, Kristin Highland, Charles A Read, Marvin J Fritzler, Grace Hyun J Kim, Chi-Hong Tseng & Robert M Elashoff. (2016) Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial. The Lancet Respiratory Medicine 4:9, pages 708-719.
Crossref
Donald P Tashkin, Elizabeth R Volkmann, Chi-Hong Tseng, Hyun J Kim, Jonathan Goldin, Philip Clements, Daniel Furst, Dinesh Khanna, Eric Kleerup, Michael D Roth & Robert Elashoff. (2016) Relationship between quantitative radiographic assessments of interstitial lung disease and physiological and clinical features of systemic sclerosis. Annals of the Rheumatic Diseases 75:2, pages 374-381.
Crossref
Nasser S. Ahmadi, Jörgen Månsson, Ulf Lindblad & Cathrine Hildingh. (2013) Breathlessness in everyday life from a patient perspective: A qualitative study using diaries. Palliative and Supportive Care 12:3, pages 189-194.
Crossref
Donald A. Mahler, Alex H. Gifford, Laurie A. Waterman, Joseph Ward, William J. Kraemer, Brian R. Kupchak & Andrew Harver. (2013) Effect of Increased Blood Levels of ?-Endorphin on Perception of Breathlessness. Chest 143:5, pages 1378-1385.
Crossref
Marie Bruyneel, Val?rie Jacob, Christina Sanida, Lieveke Ameye, Roger Sergysels & Vincent Ninane. (2011) Hoover's sign is a predictor of airflow obstruction severity and is not related to hyperinflation in chronic obstructive pulmonary disease. European Journal of Internal Medicine 22:6, pages e115-e118.
Crossref
Susan E. Yount, Seung W. Choi, David Victorson, Bernice Ruo, David Cella, Susan Anton & Alan Hamilton. (2011) Brief, Valid Measures of Dyspnea and Related Functional Limitations in Chronic Obstructive Pulmonary Disease (COPD). Value in Health 14:2, pages 307-315.
Crossref
MeiLan K. Han, Alvar Agusti, Peter M. Calverley, Bartolome R. Celli, Gerard Criner, Jeffrey L. Curtis, Leonardo M. Fabbri, Jonathan G. Goldin, Paul W. Jones, William MacNee, Barry J. Make, Klaus F. Rabe, Stephen I. Rennard, Frank C. Sciurba, Edwin K. Silverman, Jørgen Vestbo, George R. Washko, Emiel F. M. Wouters & Fernando J. Martinez. (2010) Chronic Obstructive Pulmonary Disease Phenotypes. American Journal of Respiratory and Critical Care Medicine 182:5, pages 598-604.
Crossref
Xiaolei Zhang, Laurie A. Waterman, Joseph Ward, John C. Baird & Donald A. Mahler. (2010) Advantages of Endurance Treadmill Walking Compared With Cycling To Assess Bronchodilator Therapy. Chest 137:6, pages 1354-1361.
Crossref
М. . Казолла, В. . Мак-Ни, Ф. Дж. Мартинес, К. Ф. Рабе, Л. Дж. Франчиози, П. Дж. Барнс, В. . Брусаско, П. С. Бурдж, П. М. Калверлей, Б. Р. Селли, П. В. Джонс, Д. А. Малер, Б. . Мейк, М. . Миравиттлс, С. П. Пейдж, П. . Паланьи, Д. . Парр, М. . Пистолези, С. И. Реннард, М. П. Руттен Ван Мелькен, Р. . Стокли, С. Д. Салливан, Дж. А. Ведзича & Е. Ф. Воутерс. (2010) Показатели, оцениваемые в фармакологических исследованиях ХОБЛ: от легочной функции до биомаркеров. PULMONOLOGIYA:1, pages 13-65.
Crossref
Ernesto Crisafulli & Enrico M Clini. (2010) Measures of dyspnea in pulmonary rehabilitation. Multidisciplinary Respiratory Medicine 5:3, pages 202.
Crossref
Donald A. Mahler, Joseph Ward, Laurie A. Waterman, Corliss McCusker, Richard ZuWallack & John C. Baird. (2009) Patient-Reported Dyspnea in COPD Reliability and Association With Stage of Disease. Chest 136:6, pages 1473-1479.
Crossref
Donald P. Tashkin, Nicola A. Hanania, Joe McGinty, Kimberly Denis-Mize & Imtiaz Chaudry. (2009) Nebulized formoterol provides added benefits to tiotropium treatment in chronic obstructive pulmonary disease. Advances in Therapy 26:11, pages 1024-1034.
Crossref
C. Laurendeau, C. Pribil, T. Perez, N. Roche, M.-C. Simeoni & B. Detournay. (2009) Étude de validation de l’échelle BDI/TDI dans la bronchopneumopathie chronique obstructive. Revue des Maladies Respiratoires 26:7, pages 735-743.
Crossref
Loris A. Thomas. (2009) Effective dyspnea management strategies identified by elders with end-stage chronic obstructive pulmonary disease. Applied Nursing Research 22:2, pages 79-85.
Crossref
James A. Murray, Laurie A. Waterman, Joseph Ward, John C. Baird & Donald A. Mahler. (2009) Perceptual and Physiologic Responses During Treadmill and Cycle Exercise in Patients With COPD. Chest 135:2, pages 384-390.
Crossref
Harold R Collard & Steven Z Pantilat. (2008) Dyspnea in interstitial lung disease. Current Opinion in Supportive & Palliative Care 2:2, pages 100-104.
Crossref
Donald A. Mahler, Laurie A. Waterman, Joseph Ward, Corliss McCusker, Richard ZuWallack & John C. Baird. (2007) Validity and Responsiveness of the Self-Administered Computerized Versions of the Baseline and Transition Dyspnea Indexes. Chest 132:4, pages 1283-1290.
Crossref
Robert P Baughman & Elyse E Lower. (2007) Six-minute walk test in managing and monitoring sarcoidosis patients. Current Opinion in Pulmonary Medicine 13:5, pages 439-444.
Crossref
Donald P. Tashkin, Gerald L. Klein, Shoshana S. Colman, Hany Zayed & Warren H. Schonfeld. (2007) Comparing COPD Treatment: Nebulizer, Metered Dose Inhaler, and Concomitant Therapy. The American Journal of Medicine 120:5, pages 435-441.
Crossref
C. Bausewein, M. Farquhar, S. Booth, M. Gysels & I.J. Higginson. (2007) Measurement of breathlessness in advanced disease: A systematic review. Respiratory Medicine 101:3, pages 399-410.
Crossref
Andrew L. Ries. (2006) Impact of Chronic Obstructive Pulmonary Disease on Quality of Life: The Role of Dyspnea. The American Journal of Medicine 119:10, pages 12-20.
Crossref
Paul Jones, Suzanne Lareau & Donald A. Mahler. (2005) Measuring the effects of COPD on the patient. Respiratory Medicine 99, pages S11-S18.
Crossref
. 2005. Dyspnea. Dyspnea 147 165 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.